Apart from IPF, elevated serum CCL18 levels reflected pulmonary fibrosis activity [21] and correlated with death or the progression of pulmonary disease [15,17,22] in patients with systemic sclerosis (SSc)-associated ILD. This evidence concerns the gene CCL18 and idiopathic pulmonary fibrosis.